Transcranial Photobiomodulation in Anxiety Disorders

NANot yet recruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2028

Conditions
Symptoms of Anxiety
Interventions
BEHAVIORAL

Attention bias assessment and modification

Attention bias assessment and modification involve two versions of the dot-probe task. These tasks are based on the premise that repeated attention shifts can retrain attentional biases, with the expectation that reducing attentional bias toward threats will alleviate sub-clinical anxiety symptoms.

DEVICE

Transcranial photobiomodulation

Participants will receive near-infrared light at 1064 nanometers to the right side of the forehead for 8 minutes. The investigators have introduced this form of transcranial photobiomodulation (tPBM) as a means of human cognitive enhancement, and as an adjunct for attention bias modification for the reduction of symptoms of depression. In the present study, the investigators wish to extend these findings to the use of attention bias modification for the reduction of sub-clinical anxiety.

Trial Locations (1)

78712

The University of Texas at Austin, Austin

All Listed Sponsors
lead

University of Texas at Austin

OTHER

NCT07133893 - Transcranial Photobiomodulation in Anxiety Disorders | Biotech Hunter | Biotech Hunter